Home/Matinas Biopharma/Jerome D. Jabbour
JD

Jerome D. Jabbour

Chief Executive Officer

Matinas Biopharma

Matinas Biopharma Pipeline

DrugIndicationPhase
MAT2203Invasive Fungal Infections (Candidiasis, Aspergillosis)Phase 2/3
LNC Platform DiscoveryOncology & InflammationDiscovery